Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1988-9-21
pubmed:abstractText
The comparative study of 44 isolates of Corynebacterium group D2, from urine, most frequently, shows the pathogenic role of these bacteria in urinary tract infection, with or without urinary stones. These microorganisms have an opportunistic behaviour in other non-urinary sites, and become pathogen in immunosuppressed conditions. The rapid tests as urease, glucose acidification, nitrate reductase, associated with multiple resistance to antibiotics (beta-lactams and aminosides) identify easily Corynebacterium group D2, from 48 h cultures under CO2 conditions. The results of MIC determination of 10 antibiotics, show the high activity (100% sensitivity) of vancomycin and pristinamycin, with MIC modes, respectively, 0.5 and 0.03 mg/l. These antibiotics are the most useful for the treatment of non-urinary infections. Among quinolones, the most active agents are ciprofloxacin and ofloxacin (MIC modes: 4 and 2 mg/l), so these antimicrobials could be used for the treatment of urinary tract infections caused by Corynebacterium group D2.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Ciprofloxacin, http://linkedlifedata.com/resource/pubmed/chemical/Enoxacin, http://linkedlifedata.com/resource/pubmed/chemical/Naphthyridines, http://linkedlifedata.com/resource/pubmed/chemical/Norfloxacin, http://linkedlifedata.com/resource/pubmed/chemical/Ofloxacin, http://linkedlifedata.com/resource/pubmed/chemical/Oxazines, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, Cyclic, http://linkedlifedata.com/resource/pubmed/chemical/Pipemidic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Rifampin, http://linkedlifedata.com/resource/pubmed/chemical/Tetracycline, http://linkedlifedata.com/resource/pubmed/chemical/Vancomycin, http://linkedlifedata.com/resource/pubmed/chemical/Virginiamycin
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0369-8114
pubmed:author
pubmed:issnType
Print
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
460-4
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:3136426-Anti-Bacterial Agents, pubmed-meshheading:3136426-Ciprofloxacin, pubmed-meshheading:3136426-Corynebacterium, pubmed-meshheading:3136426-Corynebacterium Infections, pubmed-meshheading:3136426-Drug Resistance, Microbial, pubmed-meshheading:3136426-Enoxacin, pubmed-meshheading:3136426-Female, pubmed-meshheading:3136426-Humans, pubmed-meshheading:3136426-Male, pubmed-meshheading:3136426-Naphthyridines, pubmed-meshheading:3136426-Norfloxacin, pubmed-meshheading:3136426-Ofloxacin, pubmed-meshheading:3136426-Oxazines, pubmed-meshheading:3136426-Peptides, Cyclic, pubmed-meshheading:3136426-Pipemidic Acid, pubmed-meshheading:3136426-Rifampin, pubmed-meshheading:3136426-Tetracycline, pubmed-meshheading:3136426-Tetracycline Resistance, pubmed-meshheading:3136426-Urinary Tract Infections, pubmed-meshheading:3136426-Vancomycin, pubmed-meshheading:3136426-Virginiamycin
pubmed:year
1988
pubmed:articleTitle
[Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
pubmed:affiliation
Laboratoire de Microbiologie, CHU Rangueil, Toulouse.
pubmed:publicationType
Journal Article, Comparative Study, English Abstract